| Parameter . | Pre . | Post 8-week . | P value . |
|---|---|---|---|
| Sex | 16 female / 9 male | - | |
| Age, years | 29.8 ± 8.4 | 29.9 ± 8.3 | - |
| Height, cm | 170.3 ± 9.9 | - | |
| Body mass, kg | 91.6 ± 16.2 | 90.7 ± 16.5 | 0.030 |
| BMI, kg/m2 | 31.5 ± 4.3 | 31.2 ± 4.4 | 0.027 |
| Waist-to-hip ratio | 0.890 ± 0.059 | 0.884 ± 0.060 | >0.1 |
| Total AT volume, L | 39.89 ± 11.13 | 39.01 ± 11.17 | 0.005 |
| Subcutaneous AT, L | 15.10 ± 5.50 | 14.57 ± 5.70 | 0.008 |
| Visceral AT, L | 3.40 ± 1.62 | 3.27 ± 1.53 | 0.047 |
| AT: lower extremities, L | 16.22 ± 4.53 | 15.92 ± 4.61 | 0.067 |
| AT: femural head, L | 0.461 ± 0.123 | 0.443 ± 0.121 | 0.016 |
| Non-AT: lower extremities, L | 17.87 ± 4.09 | 18.16 ± 3.86 | 0.073 |
| IATergo/BM, W/kg | 1.11 ± 0.22 | 1.33 ± 0.26 | <0.001 |
| VO2peakergo/BM, mL/(kg*min) | 25.10 ± 4.01 | 26.97 ± 4.64 | 0.007 |
| Systolic BP, mm Hg | 133.5 ± 13.8 | 130.4 ± 15.3 | >0.1 |
| Diastolic BP, mm Hg | 88.4 ± 12.0 | 83.5 ± 11.4 | 0.045 |
| Glucose fasting, mmol/L | 5.11 ± 0.39 | 5.02 ± 0.38 | >0.1 |
| Glucose OGTT120 min, mmol/L | 5.68 ± 1.22 | 5.52 ± 1.56 | >0.1 |
| Insulin fasting, pmol/L | 105 ± 43 | 100 ± 37 | >0.1 |
| Insulin OGTT120 min, pmol/L | 545 ± 410 | 457 ± 347 | >0.1 |
| ISIMats | 8.71 ± 5.04 | 9.22 ± 4.55 | >0.1 |
| HbA1c, mmol/mol Hb | 34.3 ± 2.6 | 33.6 ± 2.6 | 0.068 |
| Parameter . | Pre . | Post 8-week . | P value . |
|---|---|---|---|
| Sex | 16 female / 9 male | - | |
| Age, years | 29.8 ± 8.4 | 29.9 ± 8.3 | - |
| Height, cm | 170.3 ± 9.9 | - | |
| Body mass, kg | 91.6 ± 16.2 | 90.7 ± 16.5 | 0.030 |
| BMI, kg/m2 | 31.5 ± 4.3 | 31.2 ± 4.4 | 0.027 |
| Waist-to-hip ratio | 0.890 ± 0.059 | 0.884 ± 0.060 | >0.1 |
| Total AT volume, L | 39.89 ± 11.13 | 39.01 ± 11.17 | 0.005 |
| Subcutaneous AT, L | 15.10 ± 5.50 | 14.57 ± 5.70 | 0.008 |
| Visceral AT, L | 3.40 ± 1.62 | 3.27 ± 1.53 | 0.047 |
| AT: lower extremities, L | 16.22 ± 4.53 | 15.92 ± 4.61 | 0.067 |
| AT: femural head, L | 0.461 ± 0.123 | 0.443 ± 0.121 | 0.016 |
| Non-AT: lower extremities, L | 17.87 ± 4.09 | 18.16 ± 3.86 | 0.073 |
| IATergo/BM, W/kg | 1.11 ± 0.22 | 1.33 ± 0.26 | <0.001 |
| VO2peakergo/BM, mL/(kg*min) | 25.10 ± 4.01 | 26.97 ± 4.64 | 0.007 |
| Systolic BP, mm Hg | 133.5 ± 13.8 | 130.4 ± 15.3 | >0.1 |
| Diastolic BP, mm Hg | 88.4 ± 12.0 | 83.5 ± 11.4 | 0.045 |
| Glucose fasting, mmol/L | 5.11 ± 0.39 | 5.02 ± 0.38 | >0.1 |
| Glucose OGTT120 min, mmol/L | 5.68 ± 1.22 | 5.52 ± 1.56 | >0.1 |
| Insulin fasting, pmol/L | 105 ± 43 | 100 ± 37 | >0.1 |
| Insulin OGTT120 min, pmol/L | 545 ± 410 | 457 ± 347 | >0.1 |
| ISIMats | 8.71 ± 5.04 | 9.22 ± 4.55 | >0.1 |
| HbA1c, mmol/mol Hb | 34.3 ± 2.6 | 33.6 ± 2.6 | 0.068 |
Paired t tests or Wilcoxon signed rank tests when data were not normally distributed. N = 25, mean ± SD.
Abbreviations: AT, adipose tissue; BMI, body mass index; BP, blood pressure; IAT, individual aerobic threshold; BM, body mass; ergo, bicycle ergometer; ISI, insulin sensitivity index.
| Parameter . | Pre . | Post 8-week . | P value . |
|---|---|---|---|
| Sex | 16 female / 9 male | - | |
| Age, years | 29.8 ± 8.4 | 29.9 ± 8.3 | - |
| Height, cm | 170.3 ± 9.9 | - | |
| Body mass, kg | 91.6 ± 16.2 | 90.7 ± 16.5 | 0.030 |
| BMI, kg/m2 | 31.5 ± 4.3 | 31.2 ± 4.4 | 0.027 |
| Waist-to-hip ratio | 0.890 ± 0.059 | 0.884 ± 0.060 | >0.1 |
| Total AT volume, L | 39.89 ± 11.13 | 39.01 ± 11.17 | 0.005 |
| Subcutaneous AT, L | 15.10 ± 5.50 | 14.57 ± 5.70 | 0.008 |
| Visceral AT, L | 3.40 ± 1.62 | 3.27 ± 1.53 | 0.047 |
| AT: lower extremities, L | 16.22 ± 4.53 | 15.92 ± 4.61 | 0.067 |
| AT: femural head, L | 0.461 ± 0.123 | 0.443 ± 0.121 | 0.016 |
| Non-AT: lower extremities, L | 17.87 ± 4.09 | 18.16 ± 3.86 | 0.073 |
| IATergo/BM, W/kg | 1.11 ± 0.22 | 1.33 ± 0.26 | <0.001 |
| VO2peakergo/BM, mL/(kg*min) | 25.10 ± 4.01 | 26.97 ± 4.64 | 0.007 |
| Systolic BP, mm Hg | 133.5 ± 13.8 | 130.4 ± 15.3 | >0.1 |
| Diastolic BP, mm Hg | 88.4 ± 12.0 | 83.5 ± 11.4 | 0.045 |
| Glucose fasting, mmol/L | 5.11 ± 0.39 | 5.02 ± 0.38 | >0.1 |
| Glucose OGTT120 min, mmol/L | 5.68 ± 1.22 | 5.52 ± 1.56 | >0.1 |
| Insulin fasting, pmol/L | 105 ± 43 | 100 ± 37 | >0.1 |
| Insulin OGTT120 min, pmol/L | 545 ± 410 | 457 ± 347 | >0.1 |
| ISIMats | 8.71 ± 5.04 | 9.22 ± 4.55 | >0.1 |
| HbA1c, mmol/mol Hb | 34.3 ± 2.6 | 33.6 ± 2.6 | 0.068 |
| Parameter . | Pre . | Post 8-week . | P value . |
|---|---|---|---|
| Sex | 16 female / 9 male | - | |
| Age, years | 29.8 ± 8.4 | 29.9 ± 8.3 | - |
| Height, cm | 170.3 ± 9.9 | - | |
| Body mass, kg | 91.6 ± 16.2 | 90.7 ± 16.5 | 0.030 |
| BMI, kg/m2 | 31.5 ± 4.3 | 31.2 ± 4.4 | 0.027 |
| Waist-to-hip ratio | 0.890 ± 0.059 | 0.884 ± 0.060 | >0.1 |
| Total AT volume, L | 39.89 ± 11.13 | 39.01 ± 11.17 | 0.005 |
| Subcutaneous AT, L | 15.10 ± 5.50 | 14.57 ± 5.70 | 0.008 |
| Visceral AT, L | 3.40 ± 1.62 | 3.27 ± 1.53 | 0.047 |
| AT: lower extremities, L | 16.22 ± 4.53 | 15.92 ± 4.61 | 0.067 |
| AT: femural head, L | 0.461 ± 0.123 | 0.443 ± 0.121 | 0.016 |
| Non-AT: lower extremities, L | 17.87 ± 4.09 | 18.16 ± 3.86 | 0.073 |
| IATergo/BM, W/kg | 1.11 ± 0.22 | 1.33 ± 0.26 | <0.001 |
| VO2peakergo/BM, mL/(kg*min) | 25.10 ± 4.01 | 26.97 ± 4.64 | 0.007 |
| Systolic BP, mm Hg | 133.5 ± 13.8 | 130.4 ± 15.3 | >0.1 |
| Diastolic BP, mm Hg | 88.4 ± 12.0 | 83.5 ± 11.4 | 0.045 |
| Glucose fasting, mmol/L | 5.11 ± 0.39 | 5.02 ± 0.38 | >0.1 |
| Glucose OGTT120 min, mmol/L | 5.68 ± 1.22 | 5.52 ± 1.56 | >0.1 |
| Insulin fasting, pmol/L | 105 ± 43 | 100 ± 37 | >0.1 |
| Insulin OGTT120 min, pmol/L | 545 ± 410 | 457 ± 347 | >0.1 |
| ISIMats | 8.71 ± 5.04 | 9.22 ± 4.55 | >0.1 |
| HbA1c, mmol/mol Hb | 34.3 ± 2.6 | 33.6 ± 2.6 | 0.068 |
Paired t tests or Wilcoxon signed rank tests when data were not normally distributed. N = 25, mean ± SD.
Abbreviations: AT, adipose tissue; BMI, body mass index; BP, blood pressure; IAT, individual aerobic threshold; BM, body mass; ergo, bicycle ergometer; ISI, insulin sensitivity index.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
